BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4377390)

  • 1. [Beta lipoproteins and anti-streptococcal antibodies: nonspecific increases in the antistreptolysin O titer].
    Giacone GO; Duglio A; Grasso M
    Ann Osp Maria Vittoria Torino; 1974; 17(1-6):14-30. PubMed ID: 4377390
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the ASLO titer in dyslipemias].
    Domnişoru L; Dolea M; Apostoliu E; Rolea D
    Rev Med Chir Soc Med Nat Iasi; 1974 Apr; 78(2):341-5. PubMed ID: 4848246
    [No Abstract]   [Full Text] [Related]  

  • 3. [False pathologic antistreptolysin-O-titre in hyperlipoproteinemic patients].
    Zschiedrich M; Henze B
    Med Welt; 1977 Jun; 28(25):1114-7. PubMed ID: 197368
    [No Abstract]   [Full Text] [Related]  

  • 4. Streptolysin O inhibition by serum gamma G-globulin and beta-lipoprotein after blocking of nonesterified cholesterol by digitonin.
    Badin J; Barillec A
    J Lab Clin Med; 1970 Jun; 75(6):975-82. PubMed ID: 5421081
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of streptococcal infections. Antistreptolysin O titers. (1966--1967), Qalyub.
    Sorour AH; el-Kholy AM; Shahin I
    J Egypt Med Assoc; 1969; 52():Suppl 8-9:53+. PubMed ID: 5398474
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of beta-lipoprotein on antistreptolysin-O antibody titers.
    Baba R; Suzuki M; Sonozaki H; Schröter G; Torisu M
    Jpn J Microbiol; 1973 Jul; 17(4):257-64. PubMed ID: 4355346
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on antistreptolysin O activity generated in serum by microorganisms.
    Watson KC; Kerr EJ
    Br J Exp Pathol; 1976 Feb; 57(1):105-13. PubMed ID: 178333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-streptolysin O titer, fifty-five years after Todd: a reappraisal of its clinical significance.
    Aguzzi F; Rezzani A; Nespoli L; Monafo V; Burgio GR
    Boll Ist Sieroter Milan; 1988; 67(2):162-4. PubMed ID: 3228500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum inhibitors of streptolysin "O" in acute epidemic hepatitis].
    Elias A; Ciolac-Munteanu E; Iacobiciu I; Lazar Z; Sarlau A
    Arch Hyg Bakteriol; 1970 Jun; 154(1):52-7. PubMed ID: 4097644
    [No Abstract]   [Full Text] [Related]  

  • 10. [Raised antistreptolysin titer in patients with essential hypertriglyceridemia (Type IV of Fredrickson)].
    Rhomberg HP; Semenitz E; Braunsteiner H
    Schweiz Med Wochenschr; 1970 Mar; 100(10):456-9. PubMed ID: 5423730
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of the determination of HDL-cholesterol in the evaluation of arteriopathies of the lower extremities].
    Arber F; Darioli R; Monti M; Essinger A
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1969-71. PubMed ID: 7330649
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of the antistreptolysin-O titer for ascertaining the etiologic agent of angina in a pioneer camp].
    Dorofeĭchuk VG; Volenko TV; Taraniuk ZE; Nikolaeva RV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Feb; 43(2):128-9. PubMed ID: 6004837
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the detection of anti-streptococcal antibodies (anti-M; antistreptolysin O; antistreptokinase; antistreptohyaluronidase) in surgical diseases].
    Colantuono A
    Rass Int Clin Ter; 1966 Nov; 46(22):1263-70. PubMed ID: 5301990
    [No Abstract]   [Full Text] [Related]  

  • 14. [Age dependence of beta-lipoproteins in comparison with cholesterol and triglycerides in the serum of SPF rats].
    Metz A; Reinert K; Madörin M; Götz U
    Arzneimittelforschung; 1981; 31(5):809-13. PubMed ID: 7196741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of several methods of determining anti-streptolysin O].
    Grimaldi A; Telesforo P; Giuliani N; Salino L; Cela P; Cappucci M
    Quad Sclavo Diagn; 1980 Sep; 16(3):248-57. PubMed ID: 7244098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simultaneous determination of antistreptolysins O and antistreptodornases B in streptococcal cutaneous infections].
    Scheftel JM; Laplanche G; Freydière MH; Grosshans E
    Ann Dermatol Venereol; 1982; 109(12):1031-6. PubMed ID: 7171200
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-specific inhibition of streptolysin-O in certain non-streptococcal diseases].
    Mihalco F; Algeorge G; Tomas E; Maşek S
    Arch Roum Pathol Exp Microbiol; 1965 Dec; 24(4):825-30. PubMed ID: 5877557
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antistreptolysin--O titers in normal persons].
    Cengiz AT; Ozsan M; Poyraz F; Karaduman S; Miskioğlu M; Karabaş O
    Mikrobiyol Bul; 1983 Jan; 17(1):13-27. PubMed ID: 6888297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Streptococcal infections of the lymphatic ring of the pharynx and their complications from the aspect of immunologic responses. I].
    Novotný Z; Dosková M; Bozdĕch V; Chválová M
    Cesk Otolaryngol; 1985 Jun; 34(3):169-75. PubMed ID: 3893757
    [No Abstract]   [Full Text] [Related]  

  • 20. [Titer of antistreptolysin (ASO) among the general population of San Luis Potosí, S.L.P].
    Garrocho Sandoval C; Vázquez León H
    Arch Inst Cardiol Mex; 1970; 40(3):261-70. PubMed ID: 5477188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.